Biography and Research Information
OverviewAI-generated summary
Lirit N. Franks investigates the role of cannabinoid receptors, specifically CB1 and CB2, as potential therapeutic targets for cancer treatment. Their research focuses on the characterization of these receptors in human cancer cell lines, including Ewing sarcoma TC-71 and A-673 cells. Publications by Franks have explored how both natural and synthetic cannabinoids can reduce the viability of these cancer cells, suggesting a mechanism that may involve non-canonical CB receptor pathways. This work contributes to the understanding of cannabinoid receptor signaling in oncology and the development of novel anti-cancer drug strategies. Franks has a publication record of 16 papers with 458 citations and an h-index of 10. They have collaborated with several researchers at the University of Arkansas for Medical Sciences, including Alicja Urbaniak, Amal Shoeib, Azure L. Yarbrough, and Anna Radomińska‐Pandya.
Metrics
- h-index: 10
- Publications: 16
- Citations: 459
Selected Publications
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
Collaboration Network
Top Collaborators
Amal Shoeib
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Azure L. Yarbrough
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Paul L. Prather
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
1 shared publication
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Similar Researchers
Based on overlapping research topics
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cannabis and Cannabinoid Research
Katie R. Ryan
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cancer Cells and Metastasis
Azure L. Yarbrough
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cannabis and Cannabinoid Research
Hunter C Cochran
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Health Sciences Research and Education
Andrew P. Mathews
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer Cells and Metastasis
Health Sciences Research and Education
Amal Shoeib
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cannabis and Cannabinoid Research